This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: INFA, SBH, PRGO


Informatica (INFA) were downgraded at Jefferies to Hold from Buy. $36 price target. Growth profile reset, Jefferies said.

Macerich (MAC) was downgraded at Bank of America/Merrill Lynch to Neutral from Buy. $62 price target. More cautious consumer, BofA/Merrill said.

Perrigo (PRGO - Get Report) was downgraded at Morgan Stanley to Equal-Weight from Overweight. $125 price target. Risk reward now more balanced, Morgan Stanley said.

Sally Beauty Holdings (SBH - Get Report) was upgraded to Buy from Neutral at Bank of America/Merrill Lynch. $32 price target. Growth and cash generation offer upside, BofA/Merrill said.

SXC Health Solutions Corp. (SXCI) was initiated with a Buy rating at Goldman Sachs. $120 price target. Still attractive growth beyond deal.

Watsco (WSO - Get Report) initiated at Goldman Sachs with a Neutral rating. $80 price target. Fairly valued.

Weight Watchers (WTW) was downgraded at Bank of America/Merrill Lynch to Neutral from Buy. $53 price target. Company may have larger-than-expected cut to 2012 guidance, BofA/Merrill said.

Weyerhaeuser (WY) was downgraded at DA Davidson to Neutral from Buy. $23 price target. Commodity price movements result in a wash, DA Davidson said.

Stock Comments / EPS Changes

ConocoPhillips (COP) numbers were lowered at Jefferies. Shares are now seen reaching $60. Estimates were also lowered on growth only kicking in in 2013, Jefferies said. Hold rating.

HB Fuller (FUL) estimates were raised at KeyBanc through 2012. Continue to see visible levers for one of the strongest earnings trajectories in specialty chemicals, Keyband said. Buy rating and $39 price target.

WW Grainger (GWW) estimates were trimmed at UBS through 2013. Weaker macro data. Buy rating and $225 price target, UBS said.

Informatica numbers lowered at Oppenheimer. Shares are now seen reaching $46, Oppenheimer said. Estimates were also lowered on misexecution, Oppenheimer said. Outperform rating.

Informatica numbers were cut at UBS. Shares are now seen reaching $45, UBS said. Estimates were also lowered on second-quarter miss, UBS said. Buy rating.

US Airways (LCC) estimates were raised at Dahlman Rose through 2012. Lower jet fuel costs, Dahlman Rose said. Hold rating.

Macy's (M) estimates were lowered at BMO Capital Markets through 2013. Disappointing June comp store sales growth, BMO said. Market Perform rating and $41 price target.

Oracle (ORCL) price target was raised at Oppenheimer. Shares are now seen reaching $33. Database product strategy aligned with megatrends, Oppenheimer said. Outperform rating.

Seagate Technology (STX) price target was lowered at Goldman Sachs. Shares are now seen reaching $25. Negative preannouncement, Goldman said. Neutral rating.

>To submit a news tip, email:


Follow TheStreet on Twitter and become a fan on Facebook.
This article was written by a staff member of TheStreet.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
INFA $0.00 0.00%
PRGO $96.45 -0.81%
SBH $31.04 -1.30%
WSO $135.41 -0.89%
AAPL $95.03 -2.90%


Chart of I:DJI
DOW 17,830.76 -210.79 -1.17%
S&P 500 2,075.81 -19.34 -0.92%
NASDAQ 4,805.2910 -57.85 -1.19%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs